
Visa Inc
Financial Services
Visa Inc (V) Stock News
The latest V headlines and market coverage — 30 recent stories, updated throughout the day.
- The Motley Fool·
A Tale of Two Financial ETFs: How Vanguard Financials ETF (VFH) and First Trust Nasdaq Bank ETF (FTXO) Compare
Vanguard Financials ETF (VFH) offers broader financial sector exposure with a significantly lower expense ratio of 0.09% and stronger 5-year performance, while First Trust Nasdaq Bank ETF (FTXO) provides concentrated banking exposure with higher dividend yield but charges 0.60% in fees and exhibits greater volatility. VFH is recommended for most investors seeking diversification and cost efficiency.
- The Motley Fool·
VGSH vs VCSH: Which Vanguard Bond ETF Is the Better Buy in 2026?
The article compares two Vanguard short-term bond ETFs: VGSH (Treasury ETF) and VCSH (Corporate Bond ETF). Both charge 0.03% expense ratios, but VCSH offers higher yield (4.56%) with more volatility, while VGSH provides lower risk with 3.78% yield. The author recommends VGSH for current economic conditions due to recession concerns and elevated interest rates, suggesting VCSH is better suited for purchasing during economic downturns.
- GlobeNewswire Inc.·
Vivakor Signs LOI for Proposed $40 Million Acquisition of Direct Midstream
Vivakor, Inc. announced a non-binding Letter of Intent to acquire 100% of Direct Midstream, LLC for a gross purchase price of $40 million, valued at 4x Direct Midstream's targeted 2027 free cash flow of $10 million. The deal includes a $10 million capital investment by Vivakor and consideration of approximately $29 million in Series B Preferred Stock and $1 million in common stock. The acquisition aims to expand Vivakor's Permian Basin infrastructure and add produced water and oilfield waste management capabilities.
- GlobeNewswire Inc.·
Robin Energy Adds Exposure to the VLCC Segment
Robin Energy Ltd. (NASDAQ: RBNE) announced its participation in a private placement of newly established Volare Shipping Ltd., purchasing 90,000 shares at NOK 154 per share. The investment reflects strong market fundamentals in the crude tanker sector, supported by record VLCC earnings and structural tightening driven by geopolitical disruption and longer shipping routes.
- GlobeNewswire Inc.·Neutral
VCI Global Clarifies Structure of US$125 Million Standby Equity Purchase Facility, Emphasizes Flexible Capital Strategy
VCI Global announced a US$125 million standby Equity Purchase Agreement (ELOC) with Hudson Global Ventures, providing flexible capital access over 36 months without immediate share issuance. The company has not yet drawn any funds and plans to potentially allocate proceeds toward AI infrastructure, platforms, and renewable energy initiatives.
- GlobeNewswire Inc.·Neutral
AssetBuilt Announces Major U.S. Industrial Asset Sales Featuring Cutrale Florida, Aspen Aerogels Georgia, Jindal Films Oklahoma, Mil-Spec Los Angeles, R3 Lithium and Fortune 500 EV Manufacturing Assets in California
AssetBuilt announced extensive industrial equipment sales and manufacturing real estate opportunities throughout October-November 2026, featuring four major industrial real estate properties (Cutrale in Florida, Aspen Aerogels in Georgia, Jindal Films in Oklahoma, and Mil-Spec Coatings in Los Angeles) along with surplus equipment from R3 Lithium and a Fortune 500 automotive/EV manufacturer in California. The offerings span transformers, electrical infrastructure, processing equipment, robotics, and advanced EV battery manufacturing technology.
- GlobeNewswire Inc.·
Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical
Arcutis Biotherapeutics presented clinical data for ZORYVE (roflumilast) across multiple inflammatory skin conditions at major dermatology conferences. The INTEGUMENT-INFANT trial showed the drug was well-tolerated in infants aged 3-24 months with atopic dermatitis, with 34.4% achieving disease clearance at 4 weeks. Additional analyses demonstrated ZORYVE's efficacy in treating psoriasis on special sites including the scalp and genitals, with improvements in sexual function and quality of life. Real-world research highlighted concerns about long-term topical corticosteroid use, including skin thinning and systemic side effects, positioning ZORYVE as a potential alternative therapy.
- GlobeNewswire Inc.·Neutral
AI Crawlers Turned Away More Than Twice as Often, a Check to Run Before an AI Visibility Audit
Zen Media released guidance on AI visibility audits for brands that rank on Google but go unnamed in AI answers. Data shows AI crawler access denials increased to 13.47% in Q3 2026, with search and user-triggered AI requests growing from 6.51% to 11.92% between Q2 and Q3. The company's audit measures brand visibility across Claude, ChatGPT, Gemini, Perplexity, and Grok, identifying gaps between SEO performance and AI answer inclusion.
- Zacks Investment Research·
Will Caterpillar's Strong Volume Growth Keep Driving Sales Up in 2026?
Caterpillar (CAT) added $5.4 billion in first-half 2026 revenues from volume growth, with Construction Industries leading at $3.21 billion and Power & Energy contributing $1.58 billion. The company raised its 2026 sales growth forecast to mid-to-high teens, driven by strength across all three segments including infrastructure spending, data center demand, and mining activity.
- GlobeNewswire Inc.·
Global Electric Vehicle (EV) Wiring Harnesses and Connectors Market, 2026-2035 | Market to Reach $29.43 Billion as High-Voltage Systems and Zonal Architectures Drive 12.83% CAGR
The global electric vehicle wiring harnesses and connectors market is projected to grow from $8.53 billion in 2025 to $29.43 billion by 2035, driven by rising EV production, high-voltage system deployment, and zonal electrical architectures. Asia-Pacific will maintain regional leadership, with China emerging as the largest country market. Key challenges include copper price volatility and lengthy OEM qualification cycles.
- The Motley Fool·
Warren Buffett Recommends This Vanguard Fund for All Investors. If You Invest $300 Monthly, Here’s What History Says It Will Be Worth in 20 Years.
Warren Buffett recommends the Vanguard S&P 500 ETF (VOO) as a core investment for all investors, citing its low cost and broad exposure to U.S. companies. Historical data suggests that investing $300 monthly for 20 years could grow to over $220,000, based on the S&P 500's average 10% annual return. Buffett has personally invested in this fund and instructed his trustees to allocate most of his estate to similar index funds.
- Zacks Investment Research·
Bear of the Day: NVR, Inc. (NVR)
NVR Inc., a major homebuilder, is facing significant headwinds with a Zacks Rank #5 (Strong Sell) rating. The company missed Q2 earnings estimates by 11.5%, with gross margins compressing 230 basis points due to higher lot costs and land impairments. While new orders grew 9%, average sales prices fell 5%, indicating the company is buying volume through incentives at the expense of profitability. Analysts are consistently cutting forward estimates across all periods, and the stock remains in a well-defined downtrend with technical resistance at moving averages.
- GlobeNewswire Inc.·Neutral
China Airway Management Market Forecast to 2033 - Airway Management Tubes and Intubation Accessories | Revenue, Volume, Pricing, Company Share, and Growth Opportunities
ResearchAndMarkets.com released a comprehensive market report on China's airway management sector, covering historical data from 2018 and forecasts through 2033. The report segments the market into Airway Management Tubes and Intubation Accessories, providing revenue, volume, and pricing analysis. It includes 2025 company share data and profiles of key competitors to support strategic planning and investment decisions in this growing medical device market.
- GlobeNewswire Inc.·Neutral
China Adult Feeding Tubes and Formula Market Outlook to 2033 - Revenue, Volume, Pricing, and Company Share | Forecast Data Reveals Market Entry and Expansion Opportunities
ResearchAndMarkets.com released a comprehensive market report on China's adult feeding tubes and formula market through 2033, providing revenue, volume, and pricing forecasts. The report analyzes two main segments (Adult Feeding Tubes and Adult Feeding Formula) and includes competitive landscape data with 2025 company share information for key market participants.
- GlobeNewswire Inc.·Neutral
China Sterilization Equipment Market Outlook to 2033 - Chemical, Physical and Ultraviolet Sterilizers | Revenue, Volume and Pricing Trends Reveal Growth Opportunities
ResearchAndMarkets.com released a comprehensive market report on China's sterilization equipment industry covering chemical, physical, and ultraviolet sterilizers. The report provides revenue, volume, and pricing data from 2018-2033, competitive analysis of major players, and strategic insights for market entry and expansion in this growing sector.
- GlobeNewswire Inc.·
Australia Stretchers and Cots Market Outlook to 2033 - Revenue, Volume, Pricing and Company Share Forecast | Segment Growth Opens Investment and Expansion Opportunities
ResearchAndMarkets.com released a comprehensive market report on Australia's stretchers and cots sector, covering ambulance cots, emergency stretchers, manual and motorized transport stretchers through 2033. The report provides revenue forecasts, volume data, pricing analysis, and competitive landscape insights for manufacturers, healthcare suppliers, and investors. Key companies analyzed include Stryker Corp, Hill-Rom Holdings Inc, International Biomedical Ltd, and Linet Group SE.
- GlobeNewswire Inc.·Neutral
Kering : Saint Laurent annonce le départ de son directeur artistique, Anthony Vaccarello
Saint Laurent announced on October 9, 2026, that Anthony Vaccarello is departing as Creative Director after leading the house since 2016. During his tenure, Vaccarello strengthened Saint Laurent's identity and influence in fashion and culture. The company will announce a new creative direction soon.
- GlobeNewswire Inc.·Neutral
Kering: Saint Laurent announces the departure of Its creative director, anthony Vaccarello
Saint Laurent announced on October 9, 2026, that Anthony Vaccarello is departing as Creative Director after leading the House since 2016. Vaccarello is credited with strengthening Saint Laurent's identity and influence over the past decade. The House will soon announce its new creative leadership.
- Zacks Investment Research·
Zacks.com featured highlights Micron, NVIDIA and Par Pacific Holdings
Zacks highlights three profitable stocks with strong net income ratios and upside potential: Micron Technology with a 63.8% net profit margin and 133.9% expected earnings growth, NVIDIA with a 63.7% net profit margin and 93.9% expected earnings growth, and Par Pacific Holdings with a 9.9% net profit margin and 214% expected earnings growth. The analysis emphasizes that investors should focus on profitable companies with strong fundamentals despite October's historical market volatility.
- Zacks Investment Research·
Zacks.com featured highlights Enlight Renewable, Vicor and Cenovus Energy
Amid market volatility driven by rising oil prices and Treasury yields, Zacks highlights three momentum stocks as potential opportunities: Enlight Renewable Energy, Vicor Corp, and Cenovus Energy. Despite short-term weekly declines, all three stocks have shown strong year-over-year gains and are positioned as momentum plays for investors seeking sustained profits.
- GlobeNewswire Inc.·
Eric Appelman, Chief Revenue Officer von Aduro, in den Vorstand von Chemical Recycling Europe gewählt
Aduro Clean Technologies' Chief Revenue Officer Eric Appelman has been elected to the board of Chemical Recycling Europe (CRE) for the 2026-2028 term. The appointment comes as EU regulations for circular plastics are being formulated and Aduro advances its first-of-a-kind (FOAK) facility at Chemelot in the Netherlands. Appelman brings 35 years of experience in the international chemical industry and will contribute to CRE's efforts to advance policy, regulatory, and market frameworks supporting chemical recycling investments in Europe.
- The Motley Fool·
UBS Called Novo Nordisk a 'Value Trap.' Here's the Other Side of That Argument.
UBS analyst Michael Yee labeled Novo Nordisk a value trap, favoring Eli Lilly's growth prospects in the GLP-1 drug market. However, the article argues that while Eli Lilly currently leads, Novo Nordisk's strong R&D capabilities and 4.7% dividend yield make it a potential long-term turnaround story for patient investors willing to wait 5-10 years for recovery.
- GlobeNewswire Inc.·
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Ensign Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ENSG
Rosen Law Firm has filed a class action lawsuit against The Ensign Group, Inc. (NASDAQ: ENSG) on behalf of investors who purchased securities between February 10, 2022 and June 18, 2026. The lawsuit alleges that Ensign made false and misleading statements regarding its business practices, including systematic neglect of elderly residents, fraudulent Medicaid/Medicare billing, falsification of nursing assistant hours, and illegal licensing schemes. Investors who purchased during the class period may be entitled to compensation. The deadline to serve as lead plaintiff is December 7, 2026.
- GlobeNewswire Inc.·
ROSEN, LEADING INVESTOR COUNSEL, Encourages Duolingo, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DUOL
Rosen Law Firm has filed a class action lawsuit against Duolingo, Inc. on behalf of investors who purchased Class A common stock between May 2, 2025 and February 26, 2026. The lawsuit alleges that Duolingo made materially false statements regarding Daily Active User growth rates, failed to disclose that increased user friction from ads and subscription upsells was negatively impacting DAU growth, and concealed that AI-generated content was degrading product quality and user experience. The deadline to serve as lead plaintiff is December 7, 2026.
- GlobeNewswire Inc.·
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages York Space Systems Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – YSS
Rosen Law Firm is encouraging investors in York Space Systems Inc. (NYSE: YSS) to join a securities class action lawsuit with an October 30, 2026 deadline for lead plaintiff claims. The lawsuit alleges that York Space made materially false statements about its satellite software functionality, deceived the Pentagon's Space Development Agency with false advertising, and delivered satellites with incomplete mission-critical software, causing investor damages when the truth emerged.
- GlobeNewswire Inc.·
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXL
Rosen Law Firm has filed a securities class action lawsuit against Anavex Life Sciences Corp. (AVXL) on behalf of investors who purchased securities between November 26, 2025 and August 28, 2026. The lawsuit alleges that Anavex made false and misleading statements regarding inadequate internal controls, understated regulatory challenges related to misconduct by former CEO Christopher Missling, and misrepresented the company's business and prospects. The lead plaintiff deadline is November 30, 2026.
- GlobeNewswire Inc.·
AARD DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important October 13 Deadline in Securities Class Action – AARD
Rosen Law Firm announces a securities class action lawsuit against Aardvark Therapeutics, Inc. for allegedly making materially false and misleading statements regarding the safety and prospects of its drug ARD-101. Investors who purchased securities during the IPO on February 13, 2025 or between February 13, 2025 and May 14, 2026 may be eligible to join the class action. The deadline to serve as lead plaintiff is October 13, 2026.
- GlobeNewswire Inc.·
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS
Rosen Law Firm has filed securities class action lawsuits against Hims & Hers Health, Duolingo, and Ardelyx. The Hims lawsuit alleges the company made false statements regarding data privacy practices, prescription charging procedures, and failed to disclose regulatory scrutiny and potential penalties. Investors who purchased securities during specified class periods are encouraged to join the litigation before the November 2, 2026 lead plaintiff deadline.
- GlobeNewswire Inc.·
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages FuelCell Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FCEL
Rosen Law Firm is encouraging investors who purchased FuelCell Energy (FCEL) securities between June 24, 2026 and September 1, 2026 to join a class action lawsuit. The lawsuit alleges that FuelCell made false and misleading statements regarding its manufacturing capacity, production rates under a capital equipment purchase agreement with Fit Energy, and profitability. The lead plaintiff deadline is November 10, 2026.
- GlobeNewswire Inc.·
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Qfin Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QFIN
Rosen Law Firm has filed securities class action lawsuits against Qfin Holdings, FuelCell Energy, and Fluence Energy on behalf of investors who purchased securities during specified periods. The lawsuits allege that defendants made false or misleading statements regarding business resilience, financial results, and the impact of regulatory changes. Investors have until November 30, 2026 to move the court to serve as lead plaintiff.